1. Traineau, H, Aggarwal, R, Monfort, JB, et al. Treatment of calcinosis cutis in systemic sclerosis and dermatomyositis: a review of the literature. J Am Acad Dermatol 2020; 82: 317–325. DOI: 10.1016/j.jaad.2019.07.006. (accessed 16 July 2019).
Google Scholar | Crossref | Medline2. Reiter, N, El-Shabrawi, L, Leinweber, B, et al. Calcinosis cutis: part I. Diagnostic pathway. J Am Acad Dermatol 2011; 65: 1–12; quiz 13–14. DOI: 10.1016/j.jaad.2010.08.038. (accessed 18 June 2011).
Google Scholar | Crossref | Medline3. Valenzuela, A, Baron, M, Herrick, AL, et al. Calcinosis is associated with digital ulcers and osteoporosis in patients with systemic sclerosis: a Scleroderma Clinical Trials Consortium study. Semin Arthritis Rheum 2016; 46: 344–349. DOI: 10.1016/j.semarthrit.2016.05.008. (accessed 04 July 2016).
Google Scholar | Crossref | Medline4. Morgan, ND, Shah, AA, Mayes, MD, et al. Clinical and serological features of systemic sclerosis in a multicenter African American cohort: analysis of the genome research in African American scleroderma patients clinical database. Medicine (Baltimore) 2017; 96: e8980. DOI: 10.1097/md.0000000000008980. (accessed 03 February 2018).
Google Scholar | Crossref | Medline5. Cruz-Domínguez, MP, García-Collinot, G, Saavedra, MA, et al. Clinical, biochemical, and radiological characterization of the calcinosis in a cohort of Mexican patients with systemic sclerosis. Clin Rheumatol 2017; 36: 111–117. DOI: 10.1007/s10067-016-3412-9. (accessed 9 October 2016).
Google Scholar | Crossref | Medline6. Sujau, I, Ng, CT, Sthaneshwar, P, et al. Clinical and autoantibody profile in systemic sclerosis: baseline characteristics from a West Malaysian cohort. Int J Rheum Dis 2015; 18: 459–465. DOI: 10.1111/1756-185x.12322. (accessed 13 March 2014).
Google Scholar | Crossref | Medline7. Baron, M, Pope, J, Robinson, D, et al. Calcinosis is associated with digital ischaemia in systemic sclerosis-a longitudinal study. Rheumatology (Oxford) 2016; 55: 2148–2155. DOI: 10.1093/rheumatology/kew313. (accessed 7 September 2016).
Google Scholar | Crossref | Medline8. Valenzuela, A, Baron, M, Rodriguez-Reyna, TS, et al. Calcinosis is associated with ischemic manifestations and increased disability in patients with systemic sclerosis. Semin Arthritis Rheum 2020; 50: 891–896. DOI: https://doi.org/10.1016/j.semarthrit.2020.06.007.
Google Scholar9. Hoeltzel, MF, Oberle, EJ, Robinson, AB, et al. The presentation, assessment, pathogenesis, and treatment of calcinosis in juvenile dermatomyositis. Curr Rheumatol Rep 2014; 16: 467. DOI: 10.1007/s11926-014-0467-y. (accessed 5 November 2014).
Google Scholar | Crossref | Medline10. Huber, AM . Juvenile idiopathic inflammatory myopathies. Pediatr Clin North Am 2018; 65: 739–756. DOI: 10.1016/j.pcl.2018.04.006. (accessed 23 July 2018).
Google Scholar | Crossref | Medline11. Faller, G, Mistry, BJ, Tikly, M. Juvenile dermatomyositis in South African children is characterised by frequent dystropic calcification: a cross sectional study. Pediatr Rheumatol Online J 2014; 12: 2. DOI: 10.1186/1546-0096-12-2. (accessed 9 January 2014).
Google Scholar | Crossref | Medline12. Chung, MP, Richardson, C, Kirakossian, D, et al. Calcinosis biomarkers in adult and juvenile dermatomyositis. Autoimmun Rev 2020; 19: 102533. DOI: 10.1016/j.autrev.2020.102533. (accessed 3 April 2020).
Google Scholar | Crossref | Medline13. Jiang, W, Yang, H, Li, S, et al. Clinical features, treatments and outcomes of calcinosis in adult patients with dermatomyositis: a single cohort study. Rheumatology (Oxford) 2020; DOI: 10.1093/rheumatology/keaa618. (accessed 30 November 2020).
Google Scholar | Crossref14. Valenzuela, A, Chung, L, Casciola-Rosen, L, et al. Identification of clinical features and autoantibodies associated with calcinosis in dermatomyositis. JAMA Dermatol 2014; 150: 724–729. DOI: 10.1001/jamadermatol.2013.10416. (accessed 30 May 2014).
Google Scholar | Crossref | Medline15. Saini, I, Kalaivani, M, Kabra, SK. Calcinosis in juvenile dermatomyositis: frequency, risk factors and outcome. Rheumatol Int 2016; 36: 961–965. DOI: 10.1007/s00296-016-3467-6. (accessed 24 March 2016).
Google Scholar | Crossref | Medline16. Avouac, J, Mogavero, G, Guerini, H, et al. Predictive factors of hand radiographic lesions in systemic sclerosis: a prospective study. Ann Rheum Dis 2011; 70: 630–633. DOI: 10.1136/ard.2010.134304. (accessed 7 December 2010).
Google Scholar | Crossref | Medline17. Sakata, K, Kaneko, Y, Yasuoka, H, et al. Association of radiographic findings in hand X-ray with clinical features and autoantibodies in patients with systemic sclerosis. Clin Rheumatol 2020; 39: 113–118. DOI: 10.1007/s10067-019-04639-6. (accessed 20 June 2019).
Google Scholar | Crossref | Medline18. Tolosa-Vilella, C, Morera-Morales, ML, Simeón-Aznar, CP, et al. Digital ulcers and cutaneous subsets of systemic sclerosis: Clinical, immunological, nailfold capillaroscopy, and survival differences in the Spanish RESCLE Registry. Semin Arthritis Rheum 2016; 46: 200–208. DOI: 10.1016/j.semarthrit.2016.04.007. (accessed 18 June 2016).
Google Scholar | Crossref | Medline19. Lescoat, A, Coiffier, G, de Carlan, M, et al. Combination of capillaroscopic and ultrasonographic evaluations in systemic sclerosis: results of a cross-sectional study. Arthritis Care Res (Hoboken) 2018; 70: 938–943. DOI: 10.1002/acr.23413. (accessed 13 September 2017).
Google Scholar | Crossref | Medline20. Walsh, JS, Fairley, JA. Calcifying disorders of the skin. J Am Acad Dermatol 1995; 33: 693-706; quiz 707–610. DOI: 10.1016/0190-9622(95)91803-5. (accessed 1 November 1995).
Google Scholar | Crossref | Medline21. Johnstone, EM, Hutchinson, CE, Vail, A, et al. Acro-osteolysis in systemic sclerosis is associated with digital ischaemia and severe calcinosis. Rheumatology (Oxford) 2012; 51: 2234–2238. DOI: 10.1093/rheumatology/kes214. (accessed 28 August 2012).
Google Scholar | Crossref | Medline22. Fairchild, R, Chung, M, Sharpless, L, et al. Ultrasound detection of calcinosis and association with ulnar artery occlusion in patients with systemic sclerosis. Arthritis Care Res (Hoboken) 2020; DOI: 10.1002/acr.24327. (accessed 1 June 2020).
Google Scholar | Crossref | Medline23. Braun-Moscovici, Y, Furst, DE, Markovits, D, et al. Vitamin D, parathyroid hormone, and acroosteolysis in systemic sclerosis. J Rheumatol 2008; 35: 2201–2205. DOI: 10.3899/jrheum.071171. (accessed 10 October 2008).
Google Scholar | Crossref | Medline24. Omair, MA, Pagnoux, C, McDonald-Blumer, H, et al. Low bone density in systemic sclerosis. A systematic review. J Rheumatol 2013; 40: 1881–1890. DOI: 10.3899/jrheum.130032. (accessed 17 September 2013).
Google Scholar | Crossref | Medline25. Fauny, M, Bauer, E, Albuisson, E, et al. Vertebral fracture prevalence and measurement of the scanographic bone attenuation coefficient on CT-scan in patients with systemic sclerosis. Rheumatol Int 2018; 38: 1901–1910. DOI: 10.1007/s00296-018-4139-5. (accessed 23 August 2018).
Google Scholar | Crossref | Medline26. Lazzaroni, MG, Marasco, E, Campochiaro, C, et al. The clinical phenotype of Systemic Sclerosis patients with anti-PM/Scl antibodies: results from the EUSTAR cohort. Rheumatology (Oxford) 2021; DOI: 10.1093/rheumatology/keab152. (accessed 14 February 2021).
Google Scholar | Crossref | Medline27. Wodkowski, M, Hudson, M, Proudman, S, et al. Clinical correlates of monospecific anti-PM75 and anti-PM100 antibodies in a tri-nation cohort of 1574 systemic sclerosis subjects. Autoimmunity 2015; 48: 542–551. DOI: 10.3109/08916934.2015.1077231. (accessed 4 September 2015).
Google Scholar | Crossref | Medline28. D’Aoust, J, Hudson, M, Tatibouet, S, et al. Clinical and serologic correlates of anti-PM/Scl antibodies in systemic sclerosis: a multicenter study of 763 patients. Arthritis Rheumatol 2014; 66: 1608–1615. DOI: 10.1002/art.38428. (accessed 1 March 2014).
Google Scholar | Crossref | Medline29. Richardson, CPJ, Zeger, S, Wigley, F, et al. A heavy burden of calcinosis reflects cumulative disease damage in scleroderma [abstract]. Arthritis Rheumatol 2020; 72 (suppl 10).
Google Scholar30. De Lorenzo, R, Pinal-Fernandez, I, Huang, W, et al. Muscular and extramuscular clinical features of patients with anti-PM/Scl autoantibodies. Neurology 2018; 90: e2068–e2076. DOI: 10.1212/wnl.0000000000005638. (accessed 8 May 2018).
Google Scholar | Crossref | Medline31. Vayssairat, M, Hidouche, D, Abdoucheli-Baudot, N, et al. Clinical significance of subcutaneous calcinosis in patients with systemic sclerosis. Does diltiazem induce its regression? Ann Rheum Dis 1998; 57: 252–254. DOI: 10.1136/ard.57.4.252. (accessed 26 August 1998).
Google Scholar | Crossref | Medline32. Mahmood, M, Wilkinson, J, Manning, J, et al. History of surgical debridement, anticentromere antibody, and disease duration are associated with calcinosis in patients with systemic sclerosis. Scand J Rheumatol 2016; 45: 114–117. DOI: 10.3109/03009742.2015.1086432. (accessed 9 October 2015).
Google Scholar | Crossref | Medline33. Pai, S, Hsu, V. Are there risk factors for scleroderma-related calcinosis? Mod Rheumatol 2018; 28: 518–522. DOI: 10.1080/14397595.2017.1349594. (accessed 20 July 2017).
Google Scholar | Crossref | Medline34. Fredi, M, Bartoli, F, Cavazzana, I, et al. Calcinosis in poly-dermatomyositis: clinical and laboratory predictors and treatment options. Clinical and experimental rheumatology 2017; 35: 303–308. (accessed 3 December 2016).
Google Scholar | Medline35. Rider, LG, Shah, M, Mamyrova, G, et al. The myositis autoantibody phenotypes of the juvenile idiopathic inflammatory myopathies. Medicine (Baltimore) 2013; 92: 223–243. DOI: 10.1097/MD.0b013e31829d08f9. (accessed 24 July 2013).
Google Scholar | Crossref | Medline36. Tansley, SL, Betteridge, ZE, Shaddick, G, et al. Calcinosis in juvenile dermatomyositis is influenced by both anti-NXP2 autoantibody status and age at disease onset. Rheumatology (Oxford) 2014; 53: 2204–2208. DOI: 10.1093/rheumatology/keu259. (accessed 6 July 2014).
Google Scholar | Crossref | Medline37. Fiorentino, DF, Kuo, K, Chung, L, et al. Distinctive cutaneous and systemic features associated with antitranscriptional intermediary factor-1γ antibodies in adults with dermatomyositis. J Am Acad Dermatol 2015; 72: 449–455. DOI: 10.1016/j.jaad.2014.12.009. (accessed 18 January 2015).
Google Scholar | Crossref | Medline38. Bartoli, F, Fiori, G, Braschi, F, et al. Calcinosis in systemic sclerosis: subsets, distribution and complications. Rheumatology (Oxford) 2016; 55: 1610–1614. DOI: 10.1093/rheumatology/kew193. (accessed 1 June 2016).
Google Scholar | Crossref | Medline39. Gauhar, R, Wilkinson, J, Harris, J, et al. Calcinosis preferentially affects the thumb compared to other fingers in patients with systemic sclerosis. Scand J Rheumatol 2016; 45: 317–320. DOI: 10.3109/03009742.2015.1127412. (accessed 27 January 2016).
Google Scholar | Crossref | Medline40. Hughes, M, Hodgson, R, Harris, J, et al. Further evidence that calcinosis is associated with repetitive trauma in systemic sclerosis. Semin Arthritis Rheum 2020; 50: E4–e5. DOI: 10.1016/j.semarthrit.2019.07.001. (accessed 30 July 2019).
Google Scholar | Crossref41. Sari-Kouzel, H, Hutchinson, CE, Middleton, A, et al. Foot problems in patients with systemic sclerosis. Rheumatology (Oxford) 2001; 40: 410–413. DOI: 10.1093/rheumatology/40.4.410. (accessed 20 April 2001).
Google Scholar | Crossref | Medline42. Boulman, N, Slobodin, G, Rozenbaum, M, et al. Calcinosis in rheumatic diseases. Semin Arthritis Rheum 2005; 34: 805–812. DOI: 10.1016/j.semarthrit.2005.01.016. (accessed 9 June 2005).
Google Scholar | Crossref | Medline43. Balin, SJ, Wetter, DA, Andersen, LK, et al. Calcinosis cutis occurring in association with autoimmune connective tissue disease: the Mayo Clinic experience with 78 patients, 1996-2009. Arch Dermatol 2012; 148: 455–462. DOI: 10.1001/archdermatol.2011.2052. (accessed 21 December 2011).
Google Scholar | Crossref | Medline44. Chung, M, Chung, L. Management of calcinosis associated with dermatomyositis. Current Treatment Options in Rheumatology 2019; 5: 242–257. DOI: 10.1007/s40674-019-00134-w.
Google Scholar